Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined with Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaIn: Liver International, Jg. 45, 2025, Nr. 2, e70008DOI (Open Access)
-
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsIn: Viruses, Jg. 16, 2024, Nr. 4, 545DOI (Open Access)
-
Pandemic Preparedness : A Proposal for a Research Infrastructure and its Functionalities for a Resilient Health Research SystemIn: Das Gesundheitswesen, 2024, in pressDOI (Open Access)
-
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5In: Frontiers in Immunology, Jg. 14, 2023, 1150667DOI, Online Volltext (Open Access)
-
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany : Results from the SeBluCo Study 2020–2022In: Pathogens, Jg. 12, 2023, Nr. 4, 551DOI (Open Access)
-
Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant PatientsIn: Vaccines, Jg. 10, 2022, Nr. 8, 1348DOI (Open Access)
-
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 diseaseIn: PLoS ONE, Jg. 16, 2021, Nr. 10, e0258684DOI, Online Volltext (Open Access)
-
Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver FailureIn: Frontiers in Immunology, Jg. 11, 2021, S. 534731DOI, Online Volltext (Open Access)
-
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter studyIn: Journal of Clinical Virology, Jg. 142, 2021, 104932
-
Comprehensive evaluation of hepatitis e serology and molecular testing in a large cohortIn: Pathogens, Jg. 9, 2020, Nr. 2, S. 137DOI (Open Access)
-
Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological ProcessesIn: Cells, Jg. 9, 2020, Nr. 4, 1003DOI (Open Access)
-
Virale Infektionen bei LebertransplantiertenIn: Der Gastroenterologe, Jg. 15, 2020, Nr. 3, S. 227 – 234
-
Automated nucleic acid isolation methods for HDV viral load quantification can lead to viral load underestimationIn: Antiviral Therapy, Jg. 24, 2019, Nr. 2, S. 117 – 123
-
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsIn: Viruses, Jg. 11, 2019, Nr. 3, S. 275DOI (Open Access)
-
Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cellsIn: Journal of Hepatology, Jg. 71, 2019, Nr. 2, S. 301 – 312DOI, Online Volltext (Open Access)
-
Clinical Outcome and Viral Genome Variability of Hepatitis B Virus–Induced Acute Liver FailureIn: Hepatology, Jg. 69, 2019, Nr. 3, S. 993 – 1003
-
Clinical and Virological Aspects of HBV Reactivation : A Focus on Acute Liver FailureIn: Viruses, Jg. 11, 2019, Nr. 9DOI (Open Access)
-
Comparison of automated extraction and amplification platforms on quantification of plasma HDV RNA : A multicenter studyIn: Clinica Chimica Acta, Jg. 493, 2019, Nr. Suppl. 1, S. S582
-
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infectionIn: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e81
-
Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failureIn: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e181 – e182
-
Infectivity and stability of hepatitis C virus in different perfusion solutionsIn: Transplant Infectious Disease, Jg. 21, 2019, Nr. 5, S. e13135
-
Influenza virus infection as precipitating event of acute-on-chronic liver failureIn: Journal of Hepatology, Jg. 70, 2019, Nr. 4, S. 797 – 799DOI (Open Access)
-
SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variationsIn: Journal of Hepatology, Jg. 70, 2019, Nr. 4, S. 603 – 614
-
The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivationIn: Journal of Clinical Virology, Jg. 113, 2019, S. 14 – 19
-
Yellow Fever : Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging VirusIn: Viruses, Jg. 11, 2019, Nr. 10, S. 960DOI (Open Access)
-
Clinical patterns associated with the concurrent detection of anti-HBs and HBV DNAIn: Journal of Medical Virology, Jg. 90, 2018, Nr. 2, S. 282 – 290
-
Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body FluidsIn: Frontiers in Microbiology, Jg. 9, 2018, S. 504DOI (Open Access)
-
Impact of immune suppressive agents on the BK-Polyomavirus non coding control regionIn: Antiviral Research, Jg. 159, 2018, S. 68 – 76
-
Methylene Blue Treatment of Grafts During Cold Ischemia Time Reduces the Risk of Hepatitis C Virus TransmissionIn: The Journal of Infectious Diseases (JID), Jg. 218, 2018, Nr. 11, S. 1711 – 1721DOI (Open Access)
-
Role of BK polyomavirus (BKV) and torque teno virus (TTV) in liver transplant recipients with renal impairmentIn: Journal of Medical Microbiology, Jg. 67, 2018, Nr. 10, S. 1496 – 1508
-
A novel mid-scale screening assay to identify compounds with anti-HDV activityIn: Journal of Hepatology, Jg. 66, 2017, Nr. 1, S. S258
-
A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infectionIn: Antiviral Research, Jg. 141, 2017, S. 116 – 123
-
Clinical course and core variability in HBV infected patients without detectable anti-HBc antibodiesIn: Journal of Clinical Virology, Jg. 93, 2017, S. 46 – 52
-
Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral loadIn: Journal of Hepatology, Jg. 67, 2017, Nr. 2, S. 237 – 245
-
Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapyIn: Reviews in Medical Virology, Jg. 26, 2016, Nr. 5, S. 330 – 339
-
Inactivation of hepatitis C virus infectivity by human breast milkIn: The Journal of Infectious Diseases (JID), Jg. 208, 2013, Nr. 12, S. 1943 – 1952
-
Stability and transmission of hepatitis C virus in different anesthetic agentsIn: American Journal of Infection Control, Jg. 41, 2013, Nr. 10, S. 942 – 943
-
The Pepsi Project : HVC resistance screening and prediction of pi-containing therapy outcomeIn: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S489 – S490
-
Transmission of hepatitis C virus among people who inject drugs : viral stability and association with drug preparation equipmentIn: The Journal of Infectious Diseases (JID), Jg. 207, 2013, Nr. 2, S. 281 – 287
-
Inactivation and Survival of Hepatitis C Virus on Inanimate SurfacesIn: The Journal of Infectious Diseases (JID), Jg. 204, 2011, Nr. 12, S. 1830 – 1838
-
The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entryIn: Hepatology, Jg. 54, 2011, Nr. 6, S. 1947 – 1955
-
How Stable Is the Hepatitis C Virus (HCV)? : Environmental Stability of HCV and Its Susceptibility to Chemical BiocidesIn: The Journal of Infectious Diseases (JID), Jg. 201, 2010, Nr. 12, S. 1859 – 1866
-
Interim Results of a Multicentre, Open-Label Phase 2 Clinical Trial (MYR203) to Assess Safety and Efficacy of Myrcludex B in Combination with Peg-Interferon Alpha 2a in Patients with Chronic HBV/Hdv Co-InfectionIn: Hepatology. Hoboken: Wiley & Sons, Jg. 68, 2018, Nr. S1, S. 11A
-
Sodium taurocholate cotransporting popypeptide variants modulate HDV entry according to their function as a bile acid transporter but do not influence the antiviral effect of Myrcludex-BIn: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 68, 2018, Nr. Suppl. 1, S. 781
-
The presence of rare BKPYV genotypes after renal transplantation is associated with worse transplant outcome
27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,In: Transplant International. Lausanne: Frontiers Media, Jg. 31, 2018, Nr. Suppl. 5, S. 23DOI (Open Access) -
Expression Cloning of Host Factors Required for the HCV Replication CycleIn: Hepatitis C Virus Protocols. New York: Humana Press, 2019, S. 169 – 182